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Abstract
Background: Osteoarthritis (OA) is a complex arthritic condition in which the genetic factor plays a crucial role. A
single nucleotide polymorphism (SNP), rs1137101 (Gln223Arg) of leptin receptor (LEPR) gene has been
demonstrated to be associated with susceptibility to knee OA. However, this association in Chinese Han population
has never been examined. The present study aimed to investigate whether Gln223Arg was related to knee OA
susceptibility in a Northwest Chinese population with Han ethnicity.
Methods: Gln223Arg polymorphisms were genotyped in 587 patients with confirmed knee OA and in 628 age- and
sex-matched healthy controls using polymerase chain reaction-restriction fragment length polymorphism analysis.
Besides, LEPR genotypes were verified by direct DNA sequencing analysis on PCR products.
Results: The genotype and allele frequencies in LEPR SNP rs1137101 were significantly different between cases and
control groups (chi-square = 6.52, P = 0.038 for genotype and chi-square = 5.06, P = 0.024 for allele frequencies;
respectively). Rs1137101 was correlated with knee OA in the dominant genetic model (GG + GA versus AA) (P = 0.016)
and a higher G allele frequency existed (P = 0.024) among all patients with knee OA and controls. On stratification
analysis, the genotype GG and G allele were associated with susceptibility to knee OA in females, both young
(≤65 years) and old groups (>65 years) and patients with mild knee OA.
Conclusions: Our finding suggested that the genetic variant of LEPR gene rs1137101 is independently related to knee
OA susceptibility in Northwest Chinese population with Han ethnicity and may serve as a potential biomarker to
determine risk of knee OA.
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Background
Osteoarthritis (OA) is a common form of progressive joint
disorder characterized by age-related regressive changes
in articular cartilage, with joint space narrowing, osteo-
phyte formation and subcondral sclerosis [1, 2]. Common
symptoms of OA consists of severe joint pain, stiffness,
swelling, reduced motion, and a reduced quality of life.
Among different joints part in the human body, the knee
is the most common prevalent site that primary OA might
be involved. A recent survey reported the morbidity of
primary knee OA in people over 60 years is 19.4 % in
China [3]. Although the exact causes of this disease were
still not well-defined till now, it has been demonstrated to
be associated with several attributing factors including a
variety of non-genetic factors (obesity, sex, age, and joint
injury) and a combinatorial effect of genetic factors [4–6].
Therefore, there is an attractive prospect for us to find a
susceptibility gene of knee OA, which could not only
bring us a better understanding of the molecular mechan-
ism of the disease, but also benefit for the development of
OA targets drugs.
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Leptin, a endogenous hormone expressed by the obese
gene mainly in adipocytes, functions to control the
metabolism of glucose and lipid through binding to the
leptin receptor (LEPR, also known as Ob-R) [7].
Dumond et al. [8] firstly reported the expression of lep-
tin in articular cartilage and synovial fluid (SF), with only
few leptin expression in normal cartilage chondrocytes,
while in osteoarthritic cartilage and the areas of osteo-
phytes formation, the expression level of leptin was re-
markably increased and closely related to the severity of
cartilage damage. Simopoulou et al. [9] demonstrated that
leptin could induce the expression of metalloproteinases 9
and 13, 2 major enzymes that mediate the destructive
process in OA and production of inflammatory cytokine
IL-1β in chondrocytes, which contributes to the develop-
ment and progression of OA. Ku et al. [10] reported that
SF leptin concentrations in patients with knee OA was
positively associated with Kellgren/Lawrence (K/L) grad-
ing and could be used as an effective marker for quantita-
tive detection of OA severity. All these results intensively
suggested that leptin mediated a detrimental effect on car-
tilage metabolism and may thus play potential roles in the
pathogenesis of OA.
LEPR is a membrane-spanning glycoprotein belonging
to the class I cytokine-receptor family which mediates the
effects of over 20 kinds of cytokines. Among the widely
expressed alternative spliced isforms (including Ob-Ra,
Ob-Rb, Ob-Rc, Ob-Rd, and Ob-Re), the long isoform Ob-
Rb is the only 1 indentified to be functional [11]. Recent
study showed that LEPR was also expressed within the na-
tive human cartilage chondrocytes, mediating the inflam-
matory and destructive responses of leptin in cartilage and
other joint tissues [12]. Simopoulou et al. [9] detected the
expression of LEPR in articular cartilage of controls and
patients with minimal OA and demonstrated the expres-
sions of LEPR mRNA and protein were both significantly
increased in advanced osteoarthritic cartilage compared to
that of patients with minimal OA and normal controls.
Since LEPR is of functional importance for the risk factor
of OA-obesity, numerous investigations regarding the as-
sociation between LEPR SNPs with obesity have been ex-
tensively carried out [13–16]. Among the various SNPs of
LEPR, Gln223Arg (rs1137101) variant of LEPR exon 4 re-
ceived more attention. By conducting a population-based
case–control study, Portoles et al. [13] discovered the
Gln223Arg polymorphism was significantly associated
with obesity in Spain population. Other studies demon-
strated that the Gln223Arg polymorphism is highly related
to obesity in Pacific Islanders [14], body mass index
(BMI), body fat amount, serum leptin concentrations in
Caucasian woman [15] and antipsychotic-induced body
weight gain [16].
Although there have been studies demonstrating the as-
sociation of leptin gene SNPs with knee OA susceptibility
[17] and it seems that these LEPR polymorphisms are as-
sociated with risk factors for knee OA, yet few studies
have been conducted directly regarding the association of
LEPR SNPs and susceptibility to knee OA. In 2003, Ma et
al. [18]. genotyped LEPR SNP A668G (Gln223Arg) in 148
patients with knee OA and 155 controls, concluding that
Gln223Arg is associated with susceptibility to primary
knee OA in Ningxia Hui population, but this association
in Chinese Han population still remains unknown. There-
fore, the present case − control study aims to investigate
whether the genetic polymorphisms of Gln223Arg in
LEPR gene is associated with OA susceptibility in
Northwest Chinese population with Han ethnicity.
Methods
Study population
The procedure of the study was reviewed by the Ethical Re-
view Committee of Health Science Center, First Affiliated
Hospital of Xi’an Jiaotong University and conducted in line
with the Declaration of Helsinki. Written informed consent
was obtained from all participants prior to their participa-
tion in the study. A total of 1 215 subjects were recruited in
this study, consisting of 587 patients (134 males and 453
females) with confirmed knee OA and 628 age − and sex −
matched healthy controls (143 males and 485 females). The
diagnosis of OA was based on the symptomatic criteria of
American College of Rheumatology and radiographic signs
(K/L grading ≥ 2) for OA [19] of at least 1 knee. The pa-
tients were recruited at the Department of Orthopaedics,
First Affiliated Hospital of Health Science Center, Xi’an
Jiaotong University between January 2010 and December
2014. Controls with normal knee radiographs (K/L grading
< 2) undergoing physical examination were consecutively
collected in a large member of individuals contemporan-
eously. Participants were excluded on the basis of having
arthropathy due to gout, pseudogout, rheumatoid arthritis,
with histories of corticosteroid medication, bilateral knee
replacements, other forms of arthritis, cancer, or other
chronic inflammation diseases. All individuals enrolled in
the present study were drawn from a local Chinese Han
ethnic population of Shaanxi Province in Northwest China.
All subjects were stable residents in the areas and no 1
dropped out during the process of study.
Genotyping
Venous blood samples were collected from all subjects
with informed consent after overnight fasting. Genomic
DNA was all extracted from blood samples with the
commercially available DNA extraction kit (TIANGEN
Biotech, Bejing, China) according to the manufacturer’s
instructions and stored at − 80 °C until utilized. The ge-
notypes of Gln223Arg polymorphism in LEPR gene were
determined by polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP) methods.
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Sequencing primers for PCR were designed with Primer
Express 3.0 software (Applied Biosystems, Waltham, MA).
The primers used for amplification were: Forward 5′-
TCCTGCTTTAAAAGCCTAATCCAGTATTT-3′ and Re-
verse 5′-AGCTAGCAAATATTTTTGTAAGCAAT-3′ for
Gln223Arg. The PCR reaction was performed on 25 μL re-
action mixture containing 4 μL mixed DNA template, 1 μL
of each primer, 12.5 μL 2 × Reaction Mix and 6.25 μL
ddH2O. The PCR protocol was carried out as followed: ini-
tial denaturation at 95 °C for 4 min followed by 30 cycles of
94 °C for 30 s, annealing at 59.5 °C for 30 s, 72 °C for 30 s,
and a final extension at 72 °C for 7 min. PCR products were
digested over night at 37 °C with 5U ofMspI restriction en-
zymes (Thermo Scientific, Waltham, MA, USA) for
Gln223Arg polymorphisms. The digested mixtures were
then separated on a 2.0 % agarose gel and visualized by eth-
idium bromide staining and ultraviolet light transillumin-
ation. The expected fragment of Gln223Arg was 242 bp
and 125 bp in AA, 367 bp in GG and 367, 242 and 125 bp
in AG genotypes, respectively. Fifty percent of the samples
of both cases and control subjects were randomly selected
for reproducibility tests at least twice in different days by
using direct DNA sequencing with ABI3500DX Genetic
Analyzer (Thermo Scientific, Waltham, MA, USA) to verify
the accuracy of PCR-RFLP method.
Statistical analysis
Statistical analyses were performed using SPSS soft-
ware, version 16.0 for windows (SPSS Inc.; Chicago,
IL, USA). Baseline quantitative data are represented
as mean ± SD. The Chi-square goodness-of-fit test
was employed to assess the Hardy-Weinberg equilib-
rium (HWE) for genotype and allelic proportions in
the cases and control groups. The associations be-
tween the Gln223Arg polymorphism and the risk of
knee OA was evaluated with odds ratios (ORs) and
95 % confidence intervals (CI) after adjusting for age
and BMI with multivariate logistic regression analysis.
Further stratifications analysis for sex, age and the
radiographic severity of OA were subsequently con-
ducted. Kolmogorov-Smirnov test was performed to
analyze the data normality and unpaired t test,
Mann–Whitney U test, or chi-square test was used to
assess significance in clinical characteristics between
patients with knee OA and healthy controls, as ap-
propriate. Clinical characteristics of OA patients with
different genotype were compared using chi-square or
Kruskal-Wallis tests. For all the tests, P < 0.05 was
considered as statistically significant. The power of
the study was estimated with the published data in
the literature and then calculated with Power and
Precision software (Biostat, Englewood, NJ, USA),
with results reaching over 75 %.
Results
Baseline clinical parameters of the study groups
A total of 1 215 Northwest Chinese subjects with Han
ethnicity were recruited in this case–control study, com-
prising 587 patients with knee OA (134 males and 453
females; mean age 61.37 ± 10.64 years) and 628 healthy
controls (143 males and 485 females; mean age 60.46 ±
9.85 years). The baseline characteristics of both groups
were summarized in Table 1. No significant differences
in age and gender were found between the 2 groups
(P > 0.05). Similar with the previous studies that reported
high BMI increased the risk of developing OA [20], BMI
was found significantly higher in patients group com-
pared to control group (P < 0.001). According to the
radiographic KL grading system, approximately 50.3 %
of the patients had a K/L grading of 3 or 4. There were
no significant differences in the age, gender and BMI be-
tween different K/L grading subgroups (P > 0.05).
Genotypic distribution and allelic frequencies of
Gln223Arg polymorphism
The results of the genotype distribution and allele fre-
quencies of LEPR Gln223Arg for cases and control groups
were presented in Table 2. LEPR Gln223Arg variant geno-
type frequencies in either the cases or the control group
was found to be in Hardy–Weinberg equilibrium (P = 0.85
and 0.83, respectively). The genotype GG and allele-G
were the most common genotype and allele in both cases
and control groups. The allele frequencies of Gln223Arg
in cases group (G, 68.57 %; A, 31.43 %) were remarkably
different from those of control group (G, 64.25 %; A,
35.75 %, chi-square = 5.06, P = 0.024). Besides, the geno-
type distributions of Gln223Arg in cases group (GG,
45.49 %; GA, 46.17 %; AA, 8.35 %) were also significantly
different from those in control group (GG, 41.08 %; GA,
46.34 %; AA, 12.58 %; chi-square = 6.52, P = 0.038).
Association of Gln223Arg polymorphism and susceptibility
of knee OA
Table 3 illustrates the genetic association between the
Gln223Arg polymorphism of LEPR gene and risk of knee
OA. The data demonstrated that the Gln223Arg genetic
Table 1 The general characteristics of study subjects





Age (years) 61.37 ± 10.64 60.46 ± 9.85 0.537
Gender (F/M) 453/134 485/143 0.981
BMI (kg/m2) 26.31 ± 4.45 24.75 ± 4.16 <0.001
K/L grades
Grade 2, n (%) 292 (49.74) 0 (0.0) —
Grade 3, n (%) 175 (29.81) 0 (0.0) —
Grade 4, n (%) 120 (20.45) 0 (0.0) —
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polymorphism of LEPR gene was significantly related to
the susceptibility of knee OA in patients as a whole and
controls in the dominant model (GG +GA versus AA)
(OR = 1.58; 95 % CI, 1.09–2.30; P = 0.016) and G allele
was correlated with the higher risk of knee OA (OR =
1.21; 95 % CI, 1.03–1.44; P = 0.024). When further strati-
fied by sex after adjusting for other variables such as age
and BMI, multivariate logistic regression analysis showed
the evident differences of genotype distribution in female
subjects (OR = 1.89; 95 % CI, 1.25–2.87; P = 0.008).
Additionally, G allele carriers were still related to the in-
creased risk of knee OA in females (OR = 1.56; 95 % CI,
1.08–2.49; P = 0.012). However, both of the genotype distri-
butions and allele frequencies in males were found no sig-
nificant differences. When stratification by age, both young
(≤65 years) (OR = 1.48; 95 % CI, 1.18–2.36; P = 0.028) and
old (>65 years) (OR = 1.72; 95 % CI, 1.13–2.53; P = 0.020)
patients showed significant differences in combined geno-
type (GG+GA) versus AA after adjustment for BMI and
gender compared to control group. Besides, G allele car-
riers suffer higher risk of knee OA in both young (OR =
1.26; 95 % CI, 1.04–1.58; P = 0.045) and old patients (OR =
1.38; 95 % CI, 1.13–1.57; P = 0.037). After stratification ac-
cording to the radiographic severity of knee OA, significant
differences were still found to be existed in the comparison
of combined genotype (GG+GA) versus AA after adjusting
for variables such as age, BMI, and gender in cases with
mild knee OA (OR= 1.53; 95 % CI, 1.05–2.47; P = 0.022).
Additionally, G allele was moderately associated with an in-
creased risk of knee OA in mild subgroup (OR = 1.30; 95 %
CI, 1.05–1.62; P = 0.013). Unexpectedly, we didn’t detect
any association between genotype distributions or allele fre-
quencies of rs1137101 and the risk of knee OA in severe
subgroup.
Discussion
Identification of patients at risk for incident disease or
disease progression in OA remains challenging, because
the right now preferred radiography method is an in-
sensitive reflection of genetic changes that presage cartil-
age and bone abnormalities. Although the etiology of
OA is multifactorial, there have been compelling evi-
dence suggesting the involvement of genetic factors in
the pathogenesis of OA [21]. Thus, there is a widely ap-
preciated need for identification of susceptibility genes
of OA. In recent years, many studies have been inten-
sively carried out to determine the related genes that
may cause knee OA [6, 22–24]. Among which, the im-
paired leptin signal pathway was demonstrated to be
highly related to the pathophysiology of OA. Considering
the crucial role of LEPR in regulating leptin activity, here
we investigated the effects of the common exonic poly-
morphism of Gln223Arg in LEPR gene on the risk of knee
OA in Northwest Chinese population with Han ethnicity.
Table 2 The genotype and allele frequencies of rs1137101 polymorphism of LEPR gene in knee OA patients and healthy controls
Groups Number Genotype frequencies (%) Allele frequencies (%) χ2 P-value
GG AG/GA AA G A
Cases 587 267 (45.49) 271 (46.17) 49 (8.35) 805 (68.57) 369 (31.43) 2.96 0.85
Control 628 258 (41.08) 291 (46.34) 79 (12.58) 807 (64.25) 449 (35.75) 0.05 0.83
Total 1215 523 (43.05) 571 (47.00) 121 (9.96) 1617 (66.54) 813 (33.46) 1.55 0.21
χ2 = 6.52, P = 0.038 2 = 5.06, P = 0.024
Table 3 Association of the rs1137101 polymorphism of LEPR gene with risk of knee OA with stratifications by age, gender and K/L grades
Groups compared GG + GA versus AA GG versus AG + AA G allele versus A allele
OR 95 % CI P-value OR 95 % CI P-value OR 95 % CI P-value
All patients (n = 587) versus all controls (n = 628) 1.58 1.09—2.30 0.016 1.20 0.95—1.50 0.12 1.21 1.03—1.44 0.024
Gender groups
Male (124 patients vs. 143controls) 0.82 0.52—1.28 0.33 1.13 0.44—2.56 0.71 0.90 0.55—1.36 0.46
Female (453 patients vs. 485 controls) 1.89 1.25—2.87 0.008 1.28 0.85—1.75 0.53 1.56 1.08—2.49 0.012
Age groups
≤65 years (285 patients vs. 278 controls) 1.48 1.18—2.36 0.028 0.95 0.68—1.32 0.65 1.26 1.04—1.58 0.045
>65 years (302 patients vs. 350 controls) 1.72 1.13—2.53 0.020 1.13 0.84—1.56 0.18 1.38 1.13—1.57 0.037
K/L grading groups
Mild OA (292 patients vs. 628 controls) 1.53 1.05—2.47 0.022 1.08 0.86—1.29 0.31 1.30 1.05—1.62 0.013
Severe OA (295 patients vs. 628 controls) 1.05 0.67—1.64 0.84 0.95 0.70—1.30 0.73 0.98 0.78—1.25 0.91
OR odds ratio, CI conidence interval; vs. versus
AA, AG, and GG genotypes were grouped together and a 2 × 3 contingency-table analysis was performed
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The present case–control study firstly examined
whether the LEPR SNP polymorphism was correlated with
the presence of primary knee OA in Northwest Chinese
population. Our results indicated that LEPR gene SNP
rs1137101 (Gln223Arg) polymorphism was correlated
with risk of knee OA. We have found GG genotype distri-
bution and G allelic frequencies of Gln223Arg were both
significantly higher in OA patients than that of control
group, and G allele of rs1137101 is a common susceptibil-
ity allele for knee OA at least in the Han population in
Northwest China. Multivariate logistic regression indi-
cated that rs1137101 was associated with knee OA in the
dominant genetic model (GG +GA versus AA) and G al-
lele carriers of Gln223Arg had higher risks of knee OA,
which is consistent with reports from Spanish Mediterra-
nean population and Pacific Islanders [13, 14]. These 2
studies both detected the significant association of Q223R
(Gln223Arg) polymorphism and prevalence of obesity in
the dominant model for Q223R (QQ+QR versus RR) and
revealed a significant association between the 223Q carrier
genotype and obesity [13, 14]. However, the population we
examined here had a BMI in a normal range (not obese)
and significant associations of Gln223Arg and risk of knee
OA were still detected, which indicates this association is
not the only risk factor for knee OA in the Chinese Han
population and implies the possibility that the effects of
Gln223Arg appear in correlating with other genetic or en-
vironmental factors. Therefore, further studies are needed
to investigate the potential role of Gln223Arg for predict-
ing risk of knee OA in Chinese Han population in the ab-
sence of obesity.
On stratification analysis, the G allele carriers (GG+GA)
and G allele were related with knee OA susceptibility in fe-
males, both young (≤65 years) and old groups (>65 years)
and patients with mild knee OA after adjustment for other
potential confounders such as age, gender and BMI. But
the association between the risk of knee OA and rs1137101
G allele carriers (GG+GA) was stronger in female patients
(1.72-fold) and those >65 years old (1.89-fold) compared
with AA homozygote. However, it should be noted there
were no associations between Gln223Arg polymorphism
and knee OA susceptibility in male participants and pa-
tients with higher K/L grading. We assume that the
disappearance of association in male participants may be
ascribed to the relative small sample size and/or sex
disparities in the genetics of OA. Although sex disparities
in the genetics of OA have not been fully understood, in
addition to the effect of estrogen, a higher incidence and
heritability of knee OA has been reported for women than
for men [5, 25–27], as well as sex differences in cartilage
volume [28]. The lack of difference in patients with higher
K/L grading can be attributed to the possibility that
rs1137101 might just play important roles in knee OA in-
duction (with relative lower K/L grading), not in the
radiographic progression of OA and that rs1137101 may be
in linkage disequilibrium with some other more relevant al-
leles within the LEPR gene region. Previous studies of can-
didate genes for OA demonstrated different SNPs may
function differently in the induction and progression of
knee OA. ADAM12 gene was found to be involved in both
the induction and radiographic progression of knee OA
[29]. NCOR2 and CD36 genes were associated with induc-
tion of radiographic knee OA measured as either a K/L
grading of ≥2.0 or the presence of osteophytes [29], while
the polymorphisms at CILP, TNA, IL1RN and variation at
inflmmatory genes appeared to correlate with radiographic
progression over time [29–31]. Besides, mitochondrial
DNA haplogroups are also associated with the induction
and progression of knee OA [32]. Thus, polygenic effects
on the pathogenesis of knee OA should not be ignored and
there exists a necessity to explore other potentially contrib-
uting genes involved in the development of knee OA for a
better comprehension of genetic regulation on knee OA.
Originally, the SNP rs1137101 designates a change of
glutamine to an arginine at codon 223 (Gln223Arg) in the
extracellular domain coding region of the LEPR protein
[33]. This transition results in an exchange of a neutral
amino acid for 1 with a positive charge, altering receptor
structure and function and affecting signaling capacity
and circulating leptin levels [34]. Previous studies have
mostly reported the association of Gln223Arg polymorph-
ism and risk of different kinds of cancers [34–36] and car-
diovascular disease [37–39]. Gln223Arg was recently
recognized as a risk predictor of knee OA in Ningxia Hui
population, however, there have been no detailed data
concerning the association LEPR SNP rs1137101 with risk
of OA in Chinese Han population thus far. We were the
first to show that Gln223Arg polymorphism was corre-
lated with risk of knee OA in Northwest Chinese popula-
tion with Han ethnicity. The correlation between the
Gln223Arg polymorphism and knee OA susceptibility
could be possible interpreted by physiological role of lep-
tin. As described previously, leptin can also be produced
by many other tissues and cells other than adipose tissue,
such as joint tissues [8, 10]. Besides, LEPR was also
expressed within the native human cartilage, mediating
the inflammatory and destructive responses of leptin in
cartilage and other joint tissues [12]. Further mechanical
studies indicated that the Gln223Arg polymorphism
might affect leptin signaling through phosphorylation of
signal transducers and activators of transcription 3
(STAT3) [40] and was in linkage disequilibrium with other
functional polymorphisms that can impair the signaling
capacity of the LEPR [41]. The G to A mutation in
rs1137101 led to reduced proliferation and synthesis of
extracellular matrix and an amelioration of the anti-
apoptotic effect of leptin on articular chondrocytes and
eventually causes OA happen.
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However, we have been aware of several potential limi-
tations existing in this study that could affect our con-
clusions. First, as this was a study comprising a relatively
small number of subjects, it is difficult to draw a strong
conclusion. Further studies with a larger population
sample are warranted to substantiate our results. Sec-
ond, the P-value (P = 0.537) for age-matching between
patients and healthy controls appeared to be marginal,
which might affect our ability to detect the association
between Gln223Arg polymorphism and the susceptibility
of OA to some extent. Third, we have just focused on
the association and missed the aspects of the functional
study of LEPR gene polymorphism, which might poten-
tially neglect other gene SNPs that may strongly correl-
ate with OA. Lastly, we did not analyze the relationship
between Gln223Arg polymorphism and joint pain expe-
rienced by patients. Further studies are warranted to de-
tect the role of Gln223Arg polymorphism for predicting
joint pain in patients with knee OA.
Conclusions
In conclusion, this study firstly demonstrated that the LEPR
rs1137101 (Gln223Arg) polymorphism was associated with
the susceptibility of knee OA in the dominant genetic model
(GG+GA versus AA) in Northwest Chinese population
with Han ethnicity. This association remained in patients
with mild radiographic severity and female subjects. Further
studies with larger-scale population and different ethnicities
should be conducted to substantiate the current findings.
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